Navigation auf zora.uzh.ch
ZORA will change to a new software on 8th September 2025. Please note: deadline for new submissions is 21th July 2025!
Information & dates for training courses can be found here: Information on Software Migration.
Weller, M; Wick, W (2014). Neuro-oncology in 2013: improving outcome in newly diagnosed malignant glioma. Nature Reviews. Neurology, 10(2):68-70.
In 2013, two discoveries—that alkylating agent chemotherapy prolongs survival when added to radiotherapy for patients with anaplastic oligodendroglial tumours with 1p19q codeletion, and that bevacizumab prolongs progression-free survival in patients with newly diagnosed glioblastoma—have dominated debate in neuro-oncology. These findings could help to define new standards of care in malignant glioma.
| Item Type: | Journal Article, refereed, further contribution |
|---|---|
| Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology |
| Dewey Decimal Classification: | 610 Medicine & health |
| Scopus Subject Areas: | Health Sciences > Neurology (clinical)
Life Sciences > Cellular and Molecular Neuroscience |
| Language: | English |
| Date: | 2014 |
| Deposited On: | 28 Apr 2014 09:46 |
| Last Modified: | 11 Jul 2025 01:36 |
| Publisher: | Nature Publishing Group |
| ISSN: | 1759-4758 |
| OA Status: | Green |
| Publisher DOI: | https://doi.org/10.1038/nrneurol.2013.268 |
| PubMed ID: | 24419684 |
Weller, M